Essential Shared Care Agreements (ESCAs) are written agreements between specialist services and general practitioners and allow care, specifically prescribing, to be safely shared between them.
They are individual to a specific drug, detail who is responsible for what aspect of care and when early referral is required back to specialist services. They allow the seamless transfer of prescribing responsibility from the specialist services to general practice.
All ESCAs are agreed by the Trust's Medicines Optimisation Committee whose membership includes representatives from the local Clinical Care Groups (CCG). ESCAs are normally developed for all drugs, which are either specialist in nature, or that have specific monitoring requirements, e.g. a blood test is required at regular intervals.
It has been agreed by the Medicines Optimisation Committee, that where general practice refuses to enter into a shared care agreement for a drug that has been pronounced on by NICE as appropriate for shared care, the clinician should complete the Proforma for ESCA Refused by General Practice (.doc) in order that the Trust can charge the CCG appropriately.
In order that we do not charge the CCG inappropriately it is essential that, when the service is no longer providing the prescription, the clinician informs us by completing the ESCA Refused by General Practice (.doc) - service no longer prescribing as soon as possible.
The following ESCAs apply to Midlands Partnership NHS Foundation Trust (MPFT). Some of the documents are old SSSFT documents; they still apply to MPFT. They will be updated to reflect our new Trust over time.
-
Atomoxetine ESCA for patients within adult services June 2023
-
Dementia Medicines Prescribing Supportive Information (July 2022)
-
Dexamfetamine ESCA for patients within adult services June 2023
-
Fluoxetine for Children and Adolescents in Primary Care Prescribing Supportive Information Sept 2022
-
Lisdexamfetamine ESCA for patients within adult services June 2023
-
Melatonin for Children Adolescents and Adults in Primary Care Supportive Information April 2023
-
Methylphenidate ESCA for patients within adult services June 2023
Pharmacy - Information for Professionals Contact Details
Director of Pharmacy and Medicines Optimisation: Andrew Campbell
Tel: 01785 221315 Ext 7128753
Email: andrew.campbell@mpft.nhs.uk